Clinical Trial

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

Study acronym: SEED-AD
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-01-28; most recent amendment 2025-11-19.
Status change: Active, Not Recruiting → Recruiting 2025-11-19
Status change: Recruiting → Active, Not Recruiting 2023-06-05
Status change: Not Yet Recruiting → Recruiting 2019-08-28
Trial Details
NCT Number NCT03821857
Lead Sponsor Mayo Clinic
Collaborators: National Institute on Aging (NIA)
Conditions Alzheimer Disease
Enrollment 614 participants
Start Date 2019-06-27
Primary Completion 2030-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-24